Updated:
Susan G. Komen
The Susan G. Komen Breast Cancer Foundation was founded in 1982. It is a nonprofit organization that funds breast cancer research and community health...
Susan G. Komen
The Susan G. Komen Breast Cancer Foundation was founded in 1982. It is a nonprofit organization that funds breast cancer research and community health outreach. The foundation focuses on the biotech and life science sectors.
General information
Firm type
Endowment / Foundation
Year founded
1982
Location
Region
North America
Country
United States
City
Dallas
Corporate office
13770 Noel Road, Suite 801889, Dallas, TX 75380, United States
Principals
Nancy G. Brinker
Founder
Paula Schneider
Honorary Vice Chair; Former President and CEO
Ed Dandridge
Chairman of the Board
Sector focus
Frequently asked questions
Who runs investment decisions at Susan G. Komen?
The foundation's investment portfolio is overseen from its Dallas headquarters, but it does not disclose a dedicated CIO or in-house investment team lead publicly. Board members include senior executives from GoldenTree Asset Management, Blackstone, Goldman Sachs, and AVP, suggesting substantial institutional finance influence on governance and capital allocation.
What is the Susan G. Komen Breast Cancer Crypto Fund?
Komen's 'Breast Cancer Crypto Fund' is a donation-acceptance vehicle that converts cryptocurrency gifts into fiat to support research and programs. It signals the organization's willingness to engage digital-native donor bases, but the foundation has not disclosed the fund's size or whether it holds any crypto on its balance sheet as a treasury asset.
Does the foundation invest in private equity or venture capital?
Komen's portfolio includes Level 2 and 3 assets and a fund-of-funds allocation, which typically encompass private equity, venture capital, and other alternatives. The presence of private energy funds in the portfolio confirms a commitment to illiquid, manager-selected strategies beyond traditional public equities and fixed income.
How is Komen's investment portfolio structured differently from a typical foundation?
Beyond standard endowment holdings, Komen has carved out thematic allocations — private energy funds and a crypto-related vehicle — and uses a fund-of-funds approach. This structure suggests the foundation seeks both diversified grant-supporting returns and mission-aligned or opportunistic investment exposure, blending a conservative endowment posture with higher-risk satellite commitments.
What is Nancy Brinker's current role at the foundation?
Nancy G. Brinker founded the organization in 1982 and remains its most visible figure. She serves as Founder and holds ongoing leadership influence, though the foundation is currently led by a board chaired by Ed Dandridge and managed by a leadership team that most recently saw Paula Schneider serve as President and CEO until 2025.
Does Susan G. Komen maintain any philanthropic structures separate from its main foundation?
Komen's corporate structure includes the primary 'Susan G. Komen Breast Cancer Foundation, Inc.' and a similarly named entity. The organization does not publicly separate its grantmaking vehicle from a distinct donor-advised fund or supporting organization, operating as a single non-profit with chapters and international affiliates.
What corporate partnerships support Komen's funding model?
Komen runs co-branded product partnerships — an example is the 'Susan G. Komen Collection' of furniture with Hooker Furnishings Corporation — that generate royalty revenue and consumer awareness. These commercial alliances supplement individual donations, foundation grants, and investment returns to fund mission activities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: